Anti-malarial drugs chloroquine and hydroxychloroquine have been approved by the FDA as an emergency treatment in hopes to curb the number of coronavirus deaths. Doctors can now prescribe the drugs to teen and adult COVID-19 patients. However, there is inconclusive clinical proof showing if the treatment will help or not. The HHS has stated that in Germany they are already beginning to stockpile the drug form companies for use. The CDC is also warning people to stay away from nonpharmaceutical chloroquine phosphate as a treatment, due to the possible deadly side effects. Some members of the scientific community are against the use of the drugs due to there being minimal clinical trials.